TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15, 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Global MicroRNA Market Exhibits Impressive Growth with a 12.20% CAGR through 2028
April 12, 2024 10:12 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
March 28, 2024 08:30 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
Global gRNA Research Analysis Report 2024: Precision in Gene Editing and Rising Adoption of NGS Technologies Enhancing gRNA Applications
March 13, 2024 11:55 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type...
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
March 11, 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
March 11, 2024 08:15 ET
|
Napigen, Inc.
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.
Epigenetics Market Research Report 2023 - Global Forecast to 2030 with Market Share Analysis of Merck, 10X Genomics, Thermo Fisher Scientific, Illumina, and QIAGEN
March 01, 2024 04:11 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification),...
Base Editing Market Research Report 2023 - Global Forecasts to 2028: Innovative Molecules Engineered to Tackle Rare Genetic Disorders at the Fore-font of Developments
February 13, 2024 09:49 ET
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Global Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted Base...
MicroRNA Market Size is Anticipated to Reach USD 15.5 billion, at a CAGR of 29.4% CAGR by 2033 - Report by Transparency Market Research Inc.
February 02, 2024 10:50 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global micro-RNA market is estimated to flourish at a CAGR of 29.4% from 2023 to 2033....